Search

Your search keyword '"Dohi, Tomotaka"' showing total 679 results

Search Constraints

Start Over You searched for: Author "Dohi, Tomotaka" Remove constraint Author: "Dohi, Tomotaka"
679 results on '"Dohi, Tomotaka"'

Search Results

1. Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study

2. Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention

5. Relationship between coronary high-intensity plaques on T1-weighted imaging by cardiovascular magnetic resonance and vulnerable plaque features by near-infrared spectroscopy and intravascular ultrasound: a prospective cohort study

6. Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Rationale and Design of the ATLAS-OCT Study

13. Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis

25. Prognostic Impact of Culprit Lesion Calcified Nodule After Emergency Coronary Intervention: A TACTICS Registry Subanalysis

27. RELATIONSHIP BETWEEN THE EXTENT OF LIPID-RICH PLAQUE ASSESSED BY NEAR-INFRARED SPECTROSCOPY AND CLINICAL PRESENTATION: A COLOR REGISTRY ANALYSIS

28. Long-term impact of renin-angiotensin system inhibitors for secondary prevention in patients with chronic kidney disease who underwent percutaneous coronary intervention

29. TCT-341 Clinical Outcomes Following Primary Percutaneous Coronary Intervention Stratified by Angiography-Based Blood Flow Quantification

30. Effects of CPAP on Atherosclerotic Coronary Plaques in Patients with Sleep-Disordered Breathing: the ENTERPRISE Trial

33. Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI

37. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study

39. Abstract 15442: Low Serum Levels of Insulin-like Growth Factor-1 Are Associated With Long-term Risk of Adverse Cardiovascular Events in Diabetic Patients Following Percutaneous Coronary Intervention

41. Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study

49. Validation of telemedicine-based self-assessment of vital signs for patients with COVID-19: A pilot study.

50. Impact of simple equation for estimating appendicular skeletal muscle mass in patients with stable coronary artery disease undergoing percutaneous coronary intervention

Catalog

Books, media, physical & digital resources